Serum Uric Acid Levels and Nephrosclerosis in a Population-Based Autopsy Study: The Hisayama Study

Introduction: Information regarding the influence of serum uric acid (SUA) levels on pathological changes in the kidney is limited. In this study, we examined the association between SUA levels and pathological findings of nephrosclerosis in population-based autopsy samples. Methods: A total of 923...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of nephrology Vol. 53; no. 1; pp. 69 - 77
Main Authors Maki, Kenji, Hata, Jun, Sakata, Satoko, Oishi, Emi, Furuta, Yoshihiko, Nakano, Toshiaki, Oda, Yoshinao, Kitazono, Takanari, Ninomiya, Toshiharu
Format Journal Article
LanguageEnglish
Published Basel, Switzerland 01.02.2022
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Introduction: Information regarding the influence of serum uric acid (SUA) levels on pathological changes in the kidney is limited. In this study, we examined the association between SUA levels and pathological findings of nephrosclerosis in population-based autopsy samples. Methods: A total of 923 deceased individuals in a Japanese community underwent autopsy examinations between 1974 and 1994. Of these, 547 individuals with available kidney tissues and health examination data within a median of 3 years before death were eligible for the present study. SUA levels were categorized into quintiles (Q1, 107–237; Q2, 238–279; Q3, 280–326; Q4, 327–380; Q5, 381–755 μmol/L). Advanced degrees of glomerular sclerosis, kidney arteriolar hyalinosis, and kidney arteriosclerosis were defined as the 90th percentile or more of a glomerular sclerosis index and an arteriolar hyalinosis index, and the 10th percentile or less of a wall-lumen ratio, respectively. A logistic regression model was used to evaluate odds ratios (ORs) and their 95% confidence intervals (CIs) of SUA levels on each kidney lesion. Results: Higher SUA levels were significantly associated with higher values of the age- and sex-adjusted glomerular sclerosis index and lower values of the wall-lumen ratio (both p for trend <0.01). Individuals in the Q5 group had a significantly greater likelihood of advanced glomerular sclerosis (OR 7.19, 95% CI 2.42–21.38) and advanced kidney arteriosclerosis (OR 5.28, 95% CI 1.77–15.80) than individuals in the Q1 group after adjusting for potential covariates. There was no evidence of significant associations of SUA levels with either the arteriolar hyalinosis index or the presence of advanced arteriolar hyalinosis. Conclusions: Elevated SUA levels were significantly associated with advanced glomerular sclerosis and advanced kidney arteriosclerosis, but not with advanced arteriolar hyalinosis in community-based autopsy samples of Japanese.
AbstractList Introduction: Information regarding the influence of serum uric acid (SUA) levels on pathological changes in the kidney is limited. In this study, we examined the association between SUA levels and pathological findings of nephrosclerosis in population-based autopsy samples. Methods: A total of 923 deceased individuals in a Japanese community underwent autopsy examinations between 1974 and 1994. Of these, 547 individuals with available kidney tissues and health examination data within a median of 3 years before death were eligible for the present study. SUA levels were categorized into quintiles (Q1, 107–237; Q2, 238–279; Q3, 280–326; Q4, 327–380; Q5, 381–755 μmol/L). Advanced degrees of glomerular sclerosis, kidney arteriolar hyalinosis, and kidney arteriosclerosis were defined as the 90th percentile or more of a glomerular sclerosis index and an arteriolar hyalinosis index, and the 10th percentile or less of a wall-lumen ratio, respectively. A logistic regression model was used to evaluate odds ratios (ORs) and their 95% confidence intervals (CIs) of SUA levels on each kidney lesion. Results: Higher SUA levels were significantly associated with higher values of the age- and sex-adjusted glomerular sclerosis index and lower values of the wall-lumen ratio (both p for trend <0.01). Individuals in the Q5 group had a significantly greater likelihood of advanced glomerular sclerosis (OR 7.19, 95% CI 2.42–21.38) and advanced kidney arteriosclerosis (OR 5.28, 95% CI 1.77–15.80) than individuals in the Q1 group after adjusting for potential covariates. There was no evidence of significant associations of SUA levels with either the arteriolar hyalinosis index or the presence of advanced arteriolar hyalinosis. Conclusions: Elevated SUA levels were significantly associated with advanced glomerular sclerosis and advanced kidney arteriosclerosis, but not with advanced arteriolar hyalinosis in community-based autopsy samples of Japanese.
Information regarding the influence of serum uric acid (SUA) levels on pathological changes in the kidney is limited. In this study, we examined the association between SUA levels and pathological findings of nephrosclerosis in population-based autopsy samples. A total of 923 deceased individuals in a Japanese community underwent autopsy examinations between 1974 and 1994. Of these, 547 individuals with available kidney tissues and health examination data within a median of 3 years before death were eligible for the present study. SUA levels were categorized into quintiles (Q1, 107-237; Q2, 238-279; Q3, 280-326; Q4, 327-380; Q5, 381-755 μmol/L). Advanced degrees of glomerular sclerosis, kidney arteriolar hyalinosis, and kidney arteriosclerosis were defined as the 90th percentile or more of a glomerular sclerosis index and an arteriolar hyalinosis index, and the 10th percentile or less of a wall-lumen ratio, respectively. A logistic regression model was used to evaluate odds ratios (ORs) and their 95% confidence intervals (CIs) of SUA levels on each kidney lesion. Higher SUA levels were significantly associated with higher values of the age- and sex-adjusted glomerular sclerosis index and lower values of the wall-lumen ratio (both p for trend <0.01). Individuals in the Q5 group had a significantly greater likelihood of advanced glomerular sclerosis (OR 7.19, 95% CI 2.42-21.38) and advanced kidney arteriosclerosis (OR 5.28, 95% CI 1.77-15.80) than individuals in the Q1 group after adjusting for potential covariates. There was no evidence of significant associations of SUA levels with either the arteriolar hyalinosis index or the presence of advanced arteriolar hyalinosis. Elevated SUA levels were significantly associated with advanced glomerular sclerosis and advanced kidney arteriosclerosis, but not with advanced arteriolar hyalinosis in community-based autopsy samples of Japanese.
Author Oishi, Emi
Kitazono, Takanari
Nakano, Toshiaki
Oda, Yoshinao
Furuta, Yoshihiko
Sakata, Satoko
Maki, Kenji
Hata, Jun
Ninomiya, Toshiharu
Author_xml – sequence: 1
  givenname: Kenji
  surname: Maki
  fullname: Maki, Kenji
– sequence: 2
  givenname: Jun
  orcidid: 0000-0003-2698-344X
  surname: Hata
  fullname: Hata, Jun
– sequence: 3
  givenname: Satoko
  orcidid: 0000-0002-6750-5762
  surname: Sakata
  fullname: Sakata, Satoko
– sequence: 4
  givenname: Emi
  orcidid: 0000-0002-3740-4119
  surname: Oishi
  fullname: Oishi, Emi
– sequence: 5
  givenname: Yoshihiko
  orcidid: 0000-0003-2373-9636
  surname: Furuta
  fullname: Furuta, Yoshihiko
– sequence: 6
  givenname: Toshiaki
  orcidid: 0000-0001-9235-5615
  surname: Nakano
  fullname: Nakano, Toshiaki
– sequence: 7
  givenname: Yoshinao
  surname: Oda
  fullname: Oda, Yoshinao
– sequence: 8
  givenname: Takanari
  surname: Kitazono
  fullname: Kitazono, Takanari
– sequence: 9
  givenname: Toshiharu
  surname: Ninomiya
  fullname: Ninomiya, Toshiharu
  email: *Toshiharu Ninomiya, t.ninomiya.a47@m.kyushu-u.ac.jp
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35104828$$D View this record in MEDLINE/PubMed
BookMark eNpt0MtLw0AQBvBFKvahB-8iC56js688vKVFrVKq0PZctpmNXc2LbCLkvzcQ9eRlPhh-fDAzJaOiLAwhlwxuGVPRHQAoziT3T8ikD-ZFfgAjMgGuwAshUmMyde4DgPEQgjMyFoqBDHk4IYeNqduc7mqb0DixSFfmy2SO6gLp2lTHunRJZvppHbUF1fStrNpMN7YsvLl2BmncNmXlOrppWuzu6fZo6NI63elcD7tzcprqzJmLn5yR3ePDdrH0Vq9Pz4t45SUqDBvPxzSSqUIZ9AEBUwxRcR0ILlEiCgAZsQgFk8wPhNQ-GhloqXhqooSFKGbkeuit2kNucF_VNtd1t_89tgc3A_jU9bup_0D8sh7et68w7dXVv2og4htXS2tt
CitedBy_id crossref_primary_10_1007_s40620_023_01605_z
crossref_primary_10_5551_jat_64236
ContentType Journal Article
Copyright 2022 The Author(s). Published by S. Karger AG, Basel
2022 The Author(s). Published by S. Karger AG, Basel.
Copyright_xml – notice: 2022 The Author(s). Published by S. Karger AG, Basel
– notice: 2022 The Author(s). Published by S. Karger AG, Basel.
DBID M--
CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.1159/000521426
DatabaseName Karger (Open access)
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: M--
  name: Karger (Open access)
  url: https://www.karger.com/OpenAccess
  sourceTypes:
    Enrichment Source
    Publisher
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1421-9670
EndPage 77
ExternalDocumentID 35104828
521426
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
.55
.GJ
0R~
0~5
0~B
23M
30W
327
34G
36B
39C
3O-
3O.
3V.
4.4
53G
5GY
5RE
6J9
7RV
7X7
88E
88I
8AF
8AO
8FI
8FJ
8UI
AAWTL
AAYIC
ABJNI
ABPAZ
ABUWG
ACGFO
ACGFS
ACGOD
ACPRK
ACPSR
ADAGL
ADBBV
ADFRT
AENEX
AEYAO
AFFNX
AFJJK
AFKRA
AFRAH
AHMBA
ALDHI
ALIPV
ALMA_UNASSIGNED_HOLDINGS
APPQY
AZPMC
AZQEC
BENPR
BKEYQ
BPHCQ
BVXVI
CAG
CCPQU
COF
CS3
CYUIP
DWQXO
E0A
EBS
EJD
EMB
EMOBN
EX3
F5P
FB.
FYUFA
GNUQQ
HCIFZ
HMCUK
HZ~
IAO
IHR
IHW
IY7
KUZGX
M--
M1P
M2P
N9A
NAPCQ
O1H
O9-
OVD
P2P
PQQKQ
PROAC
PSQYO
RIG
RKO
RXVBD
S0X
SV3
TEORI
UJ6
UKHRP
WOW
X7M
ZGI
ZXP
CGR
CUY
CVF
ECM
EIF
ITC
NPM
ID FETCH-LOGICAL-c588t-6df94f5d4794f07151dd52a7324d4dd3004919d31416734a6de47a452fe9c18d3
IEDL.DBID M--
ISSN 0250-8095
IngestDate Sat Sep 28 08:24:38 EDT 2024
Thu Aug 29 12:04:38 EDT 2024
Thu Sep 05 17:59:11 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Population-based study
Uric acid
Nephrosclerosis
Autopsy
Language English
License This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission.
2022 The Author(s). Published by S. Karger AG, Basel.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c588t-6df94f5d4794f07151dd52a7324d4dd3004919d31416734a6de47a452fe9c18d3
ORCID 0000-0003-2373-9636
0000-0002-6750-5762
0000-0003-2698-344X
0000-0002-3740-4119
0000-0001-9235-5615
OpenAccessLink https://karger.com/doi/10.1159/000521426
PMID 35104828
PageCount 9
ParticipantIDs karger_primary_521426
pubmed_primary_35104828
PublicationCentury 2000
PublicationDate 2022-02-01
PublicationDateYYYYMMDD 2022-02-01
PublicationDate_xml – month: 02
  year: 2022
  text: 2022-02-01
  day: 01
PublicationDecade 2020
PublicationPlace Basel, Switzerland
PublicationPlace_xml – name: Basel, Switzerland
– name: Switzerland
PublicationTitle American journal of nephrology
PublicationTitleAlternate Am J Nephrol
PublicationYear 2022
References Uedono H, Tsuda A, Ishimura E, Nakatani S, Kurajoh M, Mori K, . U-shaped relationship between serum uric acid levels and intrarenal hemodynamic parameters in healthy subjects. Am J Physiol Renal Physiol. 2017;312(6):F992–7.
Nakano T, Ninomiya T, Sumiyoshi S, Fujii H, Doi Y, Hirakata H, . Association of kidney function with coronary atherosclerosis and calcification in autopsy samples from Japanese elders: the Hisayama Study. Am J Kidney Dis. 2010;55(1):21–30.
Raij L, Azar S, Keane W. Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats. Kidney Int. 1984;26(2):137–43.
Obermayr RP, Temml C, Gutjahr G, Knechtelsdorfer M, Oberbauer R, Klauser-Braun R. Elevated uric acid increases the risk for kidney disease. J Am Soc Nephrol. 2008;19(12):2407–13.
Weiner DE, Tighiouart H, Elsayed EF, Griffith JL, Salem DN, Levey AS. Uric acid and incident kidney disease in the community. J Am Soc Nephrol. 2008;19(6):1204–11.
Matsukuma Y, Masutani K, Tanaka S, Tsuchimoto A, Haruyama N, Okabe Y, . Association between serum uric acid level and renal arteriolar hyalinization in individuals without chronic kidney disease. Atherosclerosis. 2017;266:121–7.
Sugihara S, Hisatome I, Kuwabara M, Niwa K, Maharani N, Kato M, . Depletion of uric acid due to SLC22A12 (URAT1) loss-of-function mutation causes endothelial dysfunction in hypouricemia. Circ J. 2015;79(5):1125–32.
Kubo M, Kiyohara Y, Kato I, Tanizaki Y, Katafuchi R, Hirakata H, . Risk factors for renal glomerular and vascular changes in an autopsy-based population survey: the Hisayama Study. Kidney Int. 2003 Apr;63(4):1508–15.
Mun KH, Yu GI, Choi BY, Kim MK, Shin MH, Shin DH. Effect of uric acid on the development of chronic kidney disease: the Korean multi-rural communities cohort study. J Prev Med Public Health. 2018;51(5):248–56.
Tracy RE, MacLean CJ, Reed DM, Hayashi T, Gandia M, Strong JP. Blood pressure, nephrosclerosis, and age autopsy findings from the Honolulu Heart Program. Mod Pathol. 1988 Nov;1(6):420–7.
Berry CE, Hare JM. Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications. J Physiol. 2004;555(3):589–606.
Inaishi J, Saisho Y, Hirakawa Y, Yoshida D, Hata J, Mukai N, . Association of glucose tolerance status with pancreatic β- and α-cell mass in community-based autopsy samples of Japanese individuals: the Hisayama Study. J Diabetes Investig. 2020;11(5):1197–206.
Sasaki T, Izumaru K, Hata J, Sakata S, Oishi E, Nagata T, . Serum NT-proBNP levels and histopathological myocardial fibrosis in autopsied cases from a Japanese community: the Hisayama Study. J Cardiol. 2021;78(3):237–43.
Hata J, Ninomiya T, Hirakawa Y, Nagata M, Mukai N, Gotoh S, . Secular trends in cardiovascular disease and its risk factors in Japanese: half-century data from the Hisayama Study (1961–2009). Circulation. 2013;128(11):1198–205.
Nakano T, Ninomiya T, Sumiyoshi S, Onimaru M, Fujii H, Itabe H, . Chronic kidney disease is associated with neovascularization and intraplaque hemorrhage in coronary atherosclerosis in elders: results from the Hisayama Study. Kidney Int. 2013;84(2):373–80.
Kohagura K, Kochi M, Miyagi T, Kinjyo T, Maehara Y, Nagahama K, . An association between uric acid levels and renal arteriolopathy in chronic kidney disease: a biopsy-based study. Hypertens Res. 2013 Jan;36(1):43–9.
Kernohan JW, Anderson EW, Keith NM. The arterioles in cases of hypertension. Arch Intern Med. 1929;44(3):395–423.
Houston M, Estevez A, Chumley P, Aslan M, Marklund S, Parks DA, . Binding of xanthine oxidase to vascular endothelium: kinetic characterization and oxidative impairment of nitric oxide-dependent signaling. J Biol Chem. 1999;274(8):4985–94.
George J, Carr E, Davies J, Belch JJ, Struthers A. High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid. Circulation. 2006;114(23):2508–16.
Izumaru K, Hata J, Nakano T, Nakashima Y, Nagata M, Fukuhara M, . Reduced estimated GFR and cardiac remodeling: a population-based autopsy study. Am J Kidney Dis. 2019;74(3):373–81.
Ninomiya T, Kubo M, Doi Y, Yonemoto K, Tanizaki Y, Tsuruya K, . Prehypertension increases the risk for renal arteriosclerosis in autopsies: the Hisayama Study. J Am Soc Nephrol. 2007 Jul;18(7):2135–42.
Takae K, Nagata M, Hata J, Mukai N, Hirakawa Y, Yoshida D, . Serum uric acid as a risk factor for chronic kidney disease in a Japanese community: the Hisayama Study. Circ J. 2016;80(8):1857–62.
Mazzali M, Kanellis J, Han L, Feng L, Xia YY, Chen Q, . Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal Physiol. 2002;282(6):F991–7.
Ninomiya T. Japanese legacy cohort studies: the Hisayama Study. J Epidemiol. 2018;28(11):444–51.
Kang DH, Park SK, Lee IK, Johnson RJ. Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol. 2005;16(12):3553–62.
Sánchez-Lozada LG, Soto V, Tapia E, Avila-Casado C, Sautin YY, Nakagawa T, . Role of oxidative stress in the renal abnormalities induced by experimental hyperuricemia. Am J Physiol Renal Physiol. 2008;295(4):1134–41.
Kanda E, Muneyuki T, Kanno Y, Suwa K, Nakajima K. Uric acid level has a U-shaped association with loss of kidney function in healthy people: a prospective cohort study. PLoS One. 2015;10(2):e0118031.
Kumar V, Abbas AK, Aster JC. Robbins basic pathology. 10th ed.Philadelphia: Elsevier; 2018.
Burchfiel CM, Tracy RE, Chyou PH, Strong JP. Cardiovascular risk factors and hyalinization of renal arterioles at autopsy. The Honolulu Heart Program. Arterioscler Thromb Vasc Biol. 1997 Apr;17(4):760–8.
Zharikov S, Krotova K, Hu H, Baylis C, Johnson RJ, Block ER, . Uric acid decreases NO production and increases arginase activity in cultured pulmonary artery endothelial cells. Am J Physiol Cell Physiol. 2008;295(5):1183–90.
Sánchez-Lozada LG, Tapia E, López-Molina R, Nepomuceno T, Soto V, Ávila-Casado C, . Effects of acute and chronic L-arginine treatment in experimental hyperuricemia. Am J Physiol Renal Physiol. 2007;292(4):1238–44.
Wakasugi M, Kazama JJ, Narita I, Konta T, Fujimoto S, Iseki K, . Association between hypouricemia and reduced kidney function: a cross-sectional population-based study in Japan. Am J Nephrol. 2015;41(2):138–46.
Mori K, Furuhashi M, Tanaka M, Numata K, Hisasue T, Hanawa N, . U-shaped relationship between serum uric acid level and decline in renal function during a 10-year period in female subjects: BOREAS-CKD2. Hypertens Res. 2021;44(1):107–16.
Bader H, Meyer DS. The size of the juxtaglomerular apparatus in diabetic glomerulosclerosis and its correlation with arteriolosclerosis and arterial hypertension: a morphometric light microscopic study on human renal biopsies. Clin Nephrol. 1977;8(1):308–11.
References_xml
SSID ssj0012807
Score 2.3835654
Snippet Introduction: Information regarding the influence of serum uric acid (SUA) levels on pathological changes in the kidney is limited. In this study, we examined...
Information regarding the influence of serum uric acid (SUA) levels on pathological changes in the kidney is limited. In this study, we examined the...
SourceID pubmed
karger
SourceType Index Database
Enrichment Source
Publisher
StartPage 69
SubjectTerms Arteriosclerosis - diagnosis
Arteriosclerosis - epidemiology
Autopsy
Humans
Nephrosclerosis
Patient-Oriented, Translational Research: Research Article
Risk Factors
Sclerosis
Uric Acid
Title Serum Uric Acid Levels and Nephrosclerosis in a Population-Based Autopsy Study: The Hisayama Study
URI https://karger.com/doi/10.1159/000521426
https://www.ncbi.nlm.nih.gov/pubmed/35104828
Volume 53
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3PS8MwFA46Zewi_pg6nZKD14Jt07TxVsUxhi07ONhtpH0JFFk3bHfYf-9LUwsOvOSQkBbee8n3krz3PUKeRK69Jko8Ezx3mBdKJxLmAl6BLzJEXBmYbOQk5dMFmy2DZXvfYXJhvkz8c0ON2nELIOA2pecMORg_JideyJk5ZiWO070XeG1iNAI67rkiaDmE_kwdkL6PFsgiU3n91P7owJlsQGVyTs5ab5DGVn0X5EiVl6SftO_dVyTDpbxb0wVuVjTOC6AfJsanonj8p6lCPWwqnIdtUdGipJLOu3pcziviE9B4V2-21Z6aeMH9C0WroNOiknu5lrZvSBaT98-3qdNWRXDyIIpqh4MWTAdgqOE1OgiBCxB4MkTPCBiAYdASrgDfRVcr9JnkoFgoWeBpJXI3Av-a9MpNqW4Jzf0s588ZSEMaF0ZaAue5DF0NmVJZBCMytGJabS31xcpKckTGB_3xLLVDqy3oEbmxQu2Gf-V-988H78nAMwbTREOPSa_-3qkHBPs6e2z0jG06T34A6DOioQ
link.rule.ids 315,783,787,27647,27936,27937
linkProvider Karger AG
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Serum+Uric+Acid+Levels+and+Nephrosclerosis+in+a+Population-Based+Autopsy+Study%3A+The+Hisayama+Study&rft.jtitle=American+journal+of+nephrology&rft.au=Maki%2C+Kenji&rft.au=Hata%2C+Jun&rft.au=Sakata%2C+Satoko&rft.au=Oishi%2C+Emi&rft.date=2022-02-01&rft.issn=0250-8095&rft.eissn=1421-9670&rft.volume=53&rft.issue=1&rft.spage=69&rft.epage=77&rft_id=info:doi/10.1159%2F000521426&rft_id=info%3Apmid%2F35104828&rft.externalDocID=521426
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0250-8095&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0250-8095&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0250-8095&client=summon